Roles of Calcium-Sensing Receptor and Vitamin D Receptor in the Pathophysiology of Secondary Hyperparathyroidism

Journal of Renal Nutrition

Volumn 20, Issue 3, 2010, Pages 141-150

  McCann, Linda M ^a   Beto, Judith ^b  

^a CA   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM; CALCIUM SENSING RECEPTOR; MINERAL; PARATHYROID HORMONE; VITAMIN D;

BLOOD; CHRONIC KIDNEY FAILURE; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; HUMAN; HYPERPLASIA; METABOLISM; PARATHYROID GLAND; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECONDARY HYPERPARATHYROIDISM; SIGNAL TRANSDUCTION;

CALCITRIOL; CALCIUM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; KIDNEY FAILURE, CHRONIC; MINERALS; PARATHYROID GLANDS; PARATHYROID HORMONE; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 77950953237     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.01.004     Document Type: Review

References (117)

1. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (2005) 1179-1187
2. Rodriguez M., Nemeth E., and Martin D. The calcium-sensing receptor: A key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Ren Physiol 288 (2005) F253-F264
3. Martinez I., Saracho R., Montenegro J., et al. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29 (1997) 496-502
4. Owda A., Elhwairis H., Narra S., et al. Secondary hyperparathyroidism in chronic hemodialysis patients: Prevalence and race. Ren Fail 25 (2003) 595-602
5. Salem M.M. Hyperparathyroidism in the hemodialysis population: A survey of 612 patients. Am J Kidney Dis 29 (1997) 862-865
6. Block G.A., and Port F.K. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35 (2000) 1226-1237
7. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
8. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70 (2006) 771-780
9. Brown E.M., and MacLeod R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81 (2001) 239-297
10. 2+-sensing. Endocrinologist 4 (1994) 419-426
11. Shaikh A., Berndt T., and Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol 23 (2008) 1203-1210
12. Mundy G.R., and Guise T.A. Hormonal control of calcium homeostasis. Clin Chem 45 (1999) 1347-1352
13. Talmage R.V., VanderWiel C.J., and Matthews J.L. Calcitonin and phosphate. Mol Cell Endocrinol 24 (1981) 235-251
14. 2+-induced calcitonin secretion. Am J Physiol 264 (1993) E354-E360
15. Ikegame M., Ejiri S., and Ozawa H. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors. Bone 35 (2004) 27-33
16. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Ren Physiol 289 (2005) F8-F28
17. 2+-sensing receptor from bovine parathyroid. Nature 366 (1993) 575-580
18. Kifor O., Diaz R., Butters R., et al. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273 (1998) 21708-21713
19. Thiele J. The human parathyroid chief cell-A model for a polypeptide hormone producing endocrine unit as revealed by various functional and pathological conditions. A thin section and freeze-fracture study. J Submicrosc Cytol 18 (1986) 205-220
20. Garrett J.E., Capuano I.V., Hammerland L.G., et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270 (1995) 12919-12925
21. 2+-sensing receptor. J Biol Chem 282 (2007) 19000-19010
22. Brown E.M. Calcium receptor and regulation of parathyroid hormone secretion. Rev Endocr Metab Disord 1 (2000) 307-315
23. LeBoff M.S., Shoback D., Brown E.M., et al. Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest 75 (1985) 49-57
24. Brent G.A., LeBoff M.S., Seely E.W., et al. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 67 (1988) 944-950
25. Moallem E., Kilav R., Silver J., et al. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273 (1998) 5253-5259
26. Brauner-Osborne H., Jensen A.A., Sheppard P.O., et al. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 274 (1999) 18382-18386
27. National Kidney Foundation. K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 Suppl 3 (2003) S1-S201
28. Naveh-Many T., Bell O., Silver J., et al. Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. FEBS Lett 529 (2002) 60-64
29. Levi R., Ben-Dov I.Z., Lavi-Moshayoff V., et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 17 (2006) 107-112
30. Okada Y., Montero A., Zhang X., et al. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278 (2003) 21258-21266
31. McSheehy P.M., and Chambers T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118 (1986) 824-828
32. Messer H.H., Yuen S.Y., and Copp D.H. Net uptake and release of calcium and phosphate by bone in vitro: Effects of medium calcium and phosphate concentrations. Calcif Tissue Res 19 (1975) 1-7
33. Fu Q., Jilka R.L., Manolagas S.C., et al. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 277 (2002) 48868-48875
34. Hofbauer L.C., Kuhne C.A., and Viereck V. The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet Neuron Interact 4 (2004) 268-275
35. Udagawa N., Takahashi N., Jimi E., et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 25 (1999) 517-523
36. Bindels R.J. Calcium handling by the mammalian kidney. J Exp Biol 184 (1993) 89-104
37. Murer H., Hernando N., Forster I., et al. Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 80 (2000) 1373-1409
38. Healy K.D., Vanhooke J.L., Prahl J.M., et al. Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc Natl Acad Sci USA 102 (2005) 4724-4728
39. 3-1α-hydroxylase gene. Proc Natl Acad Sci USA 96 (1999) 6988-6993
40. Riccardi D., Park J., Lee W.S., et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92 (1995) 131-135
41. Chang W., Tu C., Chen T.H., et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140 (1999) 5883-5893
42. 2+-sensing receptors in intestinal epithelium. Am J Physiol 273 (1997) C1168-C1175
43. 2+-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 271 (1996) F951-F956
44. Houillier P., and Paillard M. Calcium-sensing receptor and renal cation handling. Nephrol Dial Transplant 18 (2003) 2467-2470
45. Motoyama H.I., and Friedman P.A. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Ren Physiol 283 (2002) F399-F406
46. Hendy G.N., D'Souza-Li L., Yang B., et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16 (2000) 281-296
47. Attie M.F., Gill Jr. J.R., Stock J.L., et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 72 (1983) 667-676
48. Kos C.H., Karaplis A.C., Peng J.B., et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 111 (2003) 1021-1028
49. 2+-sensing receptor promotes loss of cancellous bone. Endocrinology 148 (2007) 3156-3163
50. Kirchhoff P., and Geibel J.P. Role of calcium and other trace elements in the gastrointestinal physiology. World J Gastroenterol 12 (2006) 3229-3236
51. Cheng S.X., Okuda M., Hall A.E., et al. Expression of calcium-sensing receptor in rat colonic epithelium: Evidence for modulation of fluid secretion. Am J Physiol Gastrointest Liver Physiol 283 (2002) G240-G250
52. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: A historical perspective. Pediatrics 112 (2003) e132-e135
53. DeLuca H.F. The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 2 (1988) 224-236
54. Ghazali A., Fardellone P., Pruna A., et al. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?. Kidney Int 55 (1999) 2169-2177
55. Saab G., Young D.O., Gincherman Y., et al. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105 (2007) c132-c138
56. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the Study to Evaluate Early Kidney Disease. Kidney Int 71 (2007) 31-38
57. Chonchol M., and Scragg R. 25-hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71 (2007) 134-139
58. Wolf M., Shah A., Gutierrez O., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72 (2007) 1004-1013
59. Mirams M., Robinson B.G., Mason R.S., et al. Bone as a source of FGF23: Regulation by phosphate?. Bone 35 (2004) 1192-1199
60. Yoshiko Y., Wang H., Minamizaki T., et al. Mineralized tissue cells are a principal source of FGF23. Bone 40 (2007) 1565-1573
61. Shimada T., Kakitani M., Yamazaki Y., et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113 (2004) 561-568
62. Yamazaki Y., Tamada T., Kasai N., et al. Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23 (2008) 1509-1518
63. Shimada T., Hasegawa H., Yamazaki Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19 (2004) 429-435
64. Urena Torres P., Friedlander G., de Vernejoul M.C., et al. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73 (2008) 102-107
65. Baker A.R., McDonnell D.P., Hughes M., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85 (1988) 3294-3298
66. Brown A.J., Dusso A., and Slatopolsky E. Vitamin D. Am J Physiol 277 (1999) F157-FF175
67. Vaisanen S., Juntunen K., Itkonen A., et al. Conformational studies of human vitamin-D receptor by antipeptide antibodies, partial proteolytic digestion and ligand binding. Eur J Biochem 248 (1997) 156-162
68. Cheng J.B., Motola D.L., Mangelsdorf D.J., et al. De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxylase. J Biol Chem 278 (2003) 38084-38093
69. Masumoto O., Ohyama Y., and Okuda K. Purification and characterization of vitamin D 25-hydroxylase from rat liver mitochondria. J Biol Chem 263 (1988) 14256-14260
70. Fraser D.R., and Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 228 (1970) 764-766
71. 3 1α-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci USA 78 (1981) 1199-1203
72. Zehnder D., Bland R., Williams M.C., et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86 (2001) 888-894
73. Bikle D. Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications. Clin Rev Bone Miner Metab 7 (2009) 114-125
74. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005) 662-687
75. Li Y.C., Amling M., Pirro A.E., et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139 (1998) 4391-4396
76. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Acad Sci USA 98 (2001) 13324-13329
77. i content in vitamin D receptor null mice. Am J Physiol Ren Physiol 287 (2004) F39-F47
78. Panda D.K., Miao D., Bolivar I., et al. Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279 (2004) 16754-16766
79. Silver J., Naveh-Many T., Mayer H., et al. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78 (1986) 1296-1301
80. Brown A.J., Zhong M., Finch J., et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 270 (1996) F454-F460
81. Canaff L., and Hendy G.N. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277 (2002) 30337-30350
82. Takeyama K., Kitanaka S., Sato T., et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277 (1997) 1827-1830
83. Brenza H.L., Kimmel-Jehan C., Jehan F., et al. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci USA 95 (1998) 1387-1391
84. Bland R., Zehnder D., Hughes S.V., et al. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int 60 (2001) 1277-1286
85. Beckman M.J., and DeLuca H.F. Regulation of renal vitamin D receptor is an important determinant of 1alpha,25-dihydroxyvitamin D(3) levels in vivo. Arch Biochem Biophys 401 (2002) 44-52
86. Goodman W.G. Recent developments in the management of secondary hyperparathyroidism. Kidney Int 59 (2001) 1187-1201
87. Bover J., Jara A., Trinidad P., et al. Dynamics of skeletal resistance to parathyroid hormone in the rat: Effect of renal failure and dietary phosphorus. Bone 25 (1999) 279-285
88. Portale A.A., Halloran B.P., and Morris Jr. R.C. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83 (1989) 1494-1499
89. Bricker N.S. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N Engl J Med 286 (1972) 1093-1099
90. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44 (2004) 34-38
91. Torres A., Lorenzo V., Hernandez D., et al. Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47 (1995) 1434-1442
92. i cotransporter mRNA and protein. Am J Physiol 268 (1995) F1017-F1022
93. Naveh-Many T., and Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest 86 (1990) 1313-1319
94. Slatopolsky E., Finch J., Denda M., et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97 (1996) 2534-2540
95. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Nephrol Dial Transplant 14 (1999) 63-65
96. Drueke T.B. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 11 (2000) 1141-1152
97. Gogusev J., Duchambon P., Hory B., et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51 (1997) 328-336
98. Yano S., Sugimoto T., Tsukamoto T., et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58 (2000) 1980-1986
99. Canadillas S., Canalejo A., Santamaria R., et al. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans. J Am Soc Nephrol 16 (2005) 2190-2197
100. Mizobuchi M., Hatamura I., Ogata H., et al. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15 (2004) 2579-2587
101. Colloton M., Shatzen E., Miller G., et al. Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 67 (2005) 467-476
102. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92 (1993) 1436-1443
103. Kremer R., Bolivar I., Goltzman D., et al. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125 (1989) 935-941
104. Tokumoto M., Taniguchi M., Matsuo D., et al. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors. Ther Apher Dial 9 Suppl (2005) S27-S34
105. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
106. Drueke T.B., Touam M., Thornley-Brown D., et al. Extraskeletal calcification in patients with chronic kidney failure. Adv Nephrol Necker Hosp 30 (2000) 333-356
107. Danese M.D., Kim J., Doan Q.V., et al. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47 (2006) 149-156
108. Kovesdy C.P., Ahmadzadeh S., Anderson J.E., et al. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73 (2008) 1296-1302
109. Guerin A.P., London G.M., Marchais S.J., et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
110. Raggi P. Cardiovascular calcification in end stage renal disease. Contrib Nephrol 149 (2005) 272-278
111. Blacher J., Guerin A.P., Pannier B., et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38 (2001) 938-942
112. De Boer I.H., Gorodetskaya I., Young B., et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13 (2002) 2762-2769
113. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131-2138
114. Morena M., Terrier N., Jaussent I., et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol 17 (2005) 262-270
115. Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17 (2002) 2094-2105
116. Moe S., Drueke T., Cunningham J., et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69 (2006) 1945-1953
117. Weisinger J.R., Favus M.J., Langman C.B., et al. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J Bone Miner Res 4 (1989) 929-935